|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7800 NOK | -7.69% |
|
-7.14% | -43.48% |
| 05-29 | Exact Therapeutics' Board Proposes Delisting from Euronext Growth Oslo | MT |
| 04-09 | EXACT Therapeutics AS Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 53.46M 5.61M 4.84M 4.45M 4.18M 7.84M 530M 7.92M 52.62M 20.55M 260M 21.06M 20.61M 899M | P/E Ratio 2024 |
-2.49x | P/E Ratio 2025 | -1x |
|---|---|---|---|---|---|
| Enterprise Value | 29.55M 3.1M 2.67M 2.46M 2.31M 4.34M 293M 4.38M 29.08M 11.36M 144M 11.64M 11.39M 497M | EV / Sales 2024 |
-
| EV / Sales 2025 | 1,074,437,000x |
| Free-Float |
30.97% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -7.69% | ||
| 1 week | -7.14% | ||
| Current month | -10.34% | ||
| 1 month | -39.53% | ||
| 3 months | -70.23% | ||
| 6 months | -41.35% | ||
| Current year | -43.48% |
| 1 week | 0.58 |  | 0.93 |
| 1 month | 0.58 | | 1.56 |
| Current year | 0.58 | | 2.7 |
| 1 year | 0.58 | | 3 |
| 3 years | 0.58 | | 20 |
| 5 years | 0.58 | | 26 |
| 10 years | 0.58 | | 53.59 |
| Manager | Title | Age | Since |
|---|---|---|---|
Svein Kvåle
COO | Chief Operating Officer | - | 01/01/2012 |
Per Walday
CEO | Chief Executive Officer | 66 | 06/06/2022 |
John Edminson
DFI | Director of Finance/CFO | - | 01/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 55 | 22/06/2018 | |
Anders Wold
CHM | Chairman | - | 08/06/2022 |
| Director/Board Member | 59 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04/01/23 | Buy | Chairman | 2,500 | 0.0083% | ||
| 04/01/23 | Buy | Chief Financial Officer | 2,500 | 0.0083% | ||
| 04/01/23 | Buy | Chief Executive Officer | 2,500 | 0.0083% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.69% | -7.14% | -72.92% | -93.50% | 5.63M | |
| +0.96% | +1.16% | -12.70% | -12.33% | 43.03B | |
| +3.29% | +7.49% | +301.35% | +534.90% | 32.71B | |
| -1.64% | -2.86% | +12.04% | -17.69% | 30.29B | |
| +0.54% | -2.02% | +0.35% | +31.98% | 29.4B | |
| +1.16% | +2.10% | +14.27% | +22.05% | 25.08B | |
| +2.41% | +8.38% | - | - | 13.54B | |
| -0.31% | +1.74% | +54.78% | +111.17% | 13.35B | |
| -1.09% | -2.31% | +3.49% | +5.00% | 12.97B | |
| +0.18% | -0.18% | +108.31% | +76.09% | 12.11B | |
| Average | -0.24% | +1.94% | +45.44% | +73.08% | 21.25B | |
| Weighted average by Cap. | +0.73% | +0.82% | +60.98% | +102.52% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 0.06 0.01 0.01 0 0 0.01 0.59 0.01 0.06 0.02 0.29 0.02 0.02 0.99 |
| Net income | -52.33M -5.49M -4.73M -4.36M -4.09M -7.68M -519M -7.76M -51.51M -20.12M -254M -20.61M -20.18M -880M | -86.97M -9.13M -7.87M -7.24M -6.79M -12.76M -863M -12.89M -85.61M -33.44M -422M -34.26M -33.53M -1.46B |
| Net Debt | -98.89M -10.38M -8.95M -8.23M -7.72M -14.51M -981M -14.65M -97.34M -38.02M -480M -38.95M -38.13M -1.66B | -23.91M -2.51M -2.16M -1.99M -1.87M -3.51M -237M -3.54M -23.54M -9.19M -116M -9.42M -9.22M -402M |
Employees
11
Calendar
09-03 -
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/06/26 | 0.7800 kr | -7.69% | 116,017 |
| 12/06/26 | 0.8450 kr | +19.01% | 153,619 |
| 11/06/26 | 0.7100 kr | -14.97% | 22,010 |
| 10/06/26 | 0.8350 kr | 0.00% | 0 |
| 09/06/26 | 0.8350 kr | -0.60% | 80,791 |
- Stock Market
- Stocks
- EXTX Stock
Select your edition
All financial news and data tailored to specific country editions
